
Pancham Bakshi
Examiner (ID: 669, Phone: (571)270-3463 , Office: P/1671 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1671, 1623, 1673, 1621 |
| Total Applications | 1502 |
| Issued Applications | 1033 |
| Pending Applications | 143 |
| Abandoned Applications | 358 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16246095
[patent_doc_number] => 10745436
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-18
[patent_title] => Neuroactive steroids, compositions, and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/269779
[patent_app_country] => US
[patent_app_date] => 2019-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31912
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 273
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16269779
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/269779 | Neuroactive steroids, compositions, and uses thereof | Feb 6, 2019 | Issued |
Array
(
[id] => 14406539
[patent_doc_number] => 20190169113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => Ketamine Derivatives
[patent_app_type] => utility
[patent_app_number] => 16/269015
[patent_app_country] => US
[patent_app_date] => 2019-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13763
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16269015
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/269015 | Ketamine Derivatives | Feb 5, 2019 | Abandoned |
Array
(
[id] => 14649355
[patent_doc_number] => 20190231806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => Metformin Compositions and Methods for Treatment of Diabetes
[patent_app_type] => utility
[patent_app_number] => 16/264595
[patent_app_country] => US
[patent_app_date] => 2019-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16264595
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/264595 | Metformin compositions and methods for treatment of diabetes | Jan 30, 2019 | Issued |
Array
(
[id] => 17648487
[patent_doc_number] => 11351188
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Folic compositions and methods for treatment of diabetic neuropathies
[patent_app_type] => utility
[patent_app_number] => 16/264609
[patent_app_country] => US
[patent_app_date] => 2019-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5625
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16264609
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/264609 | Folic compositions and methods for treatment of diabetic neuropathies | Jan 30, 2019 | Issued |
Array
(
[id] => 16621479
[patent_doc_number] => 20210040132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => NOVEL COMPOUND FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASE AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/967092
[patent_app_country] => US
[patent_app_date] => 2019-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7046
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967092
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967092 | Compound for preventing or treating neurodegenerative disease and application thereof | Jan 28, 2019 | Issued |
Array
(
[id] => 16540967
[patent_doc_number] => 20200407380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => ORGANOMETALLIC COMPOUNDS AND THIN FILM USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/968492
[patent_app_country] => US
[patent_app_date] => 2019-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968492
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/968492 | Organometallic compounds and thin film using same | Jan 24, 2019 | Issued |
Array
(
[id] => 15132623
[patent_doc_number] => 10479758
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-19
[patent_title] => Hafnium-based metal-organic frameworks as epoxide ring-opening catalysts
[patent_app_type] => utility
[patent_app_number] => 16/256141
[patent_app_country] => US
[patent_app_date] => 2019-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8145
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16256141
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/256141 | Hafnium-based metal-organic frameworks as epoxide ring-opening catalysts | Jan 23, 2019 | Issued |
Array
(
[id] => 14621677
[patent_doc_number] => 20190224206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => METABOLITES OF BICTEGRAVIR
[patent_app_type] => utility
[patent_app_number] => 16/251454
[patent_app_country] => US
[patent_app_date] => 2019-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16251454
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/251454 | Metabolites of bictegravir | Jan 17, 2019 | Issued |
Array
(
[id] => 15483177
[patent_doc_number] => 10556921
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-11
[patent_title] => Dehydrogenation of neat formic acid
[patent_app_type] => utility
[patent_app_number] => 16/246872
[patent_app_country] => US
[patent_app_date] => 2019-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 23
[patent_no_of_words] => 11187
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16246872
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/246872 | Dehydrogenation of neat formic acid | Jan 13, 2019 | Issued |
Array
(
[id] => 14566873
[patent_doc_number] => 20190211043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => COMPOSITIONS AND METHODS COMPRISING CONDUCTIVE METAL ORGANIC FRAMEWORKS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/240629
[patent_app_country] => US
[patent_app_date] => 2019-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15221
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16240629
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/240629 | Compositions and methods comprising conductive metal organic frameworks and uses thereof | Jan 3, 2019 | Issued |
Array
(
[id] => 14682231
[patent_doc_number] => 20190240230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => METHOD OF TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/237867
[patent_app_country] => US
[patent_app_date] => 2019-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23358
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16237867
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/237867 | METHOD OF TREATING CANCER | Jan 1, 2019 | Abandoned |
Array
(
[id] => 17769363
[patent_doc_number] => 11401290
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-02
[patent_title] => Cobalt precursor, method of preparing same and method of manufacturing thin film using same
[patent_app_type] => utility
[patent_app_number] => 16/627243
[patent_app_country] => US
[patent_app_date] => 2018-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3042
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16627243
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/627243 | Cobalt precursor, method of preparing same and method of manufacturing thin film using same | Dec 26, 2018 | Issued |
Array
(
[id] => 14497585
[patent_doc_number] => 20190192447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => COMPOSITIONS CONTAINING THYMOHYDROQUINONE AND THEIR METHOD OF PREPARATION
[patent_app_type] => utility
[patent_app_number] => 16/232197
[patent_app_country] => US
[patent_app_date] => 2018-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2829
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 350
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16232197
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/232197 | Compositions containing thymohydroquinone and their method of preparation | Dec 25, 2018 | Issued |
Array
(
[id] => 17452984
[patent_doc_number] => 11267829
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-08
[patent_title] => Functional, partially-fluorinated silanes
[patent_app_type] => utility
[patent_app_number] => 17/274660
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5795
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17274660
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/274660 | Functional, partially-fluorinated silanes | Dec 19, 2018 | Issued |
| 16/220636 | 2-ACETYLNAPHTHO[2,3-B]FURAN -4,9-DIONE FOR USE ON TREATING CANCER | Dec 13, 2018 | Abandoned |
Array
(
[id] => 14099095
[patent_doc_number] => 20190091223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => Inhibitors of Multidrug Resistance Transporter P-Glycoprotein
[patent_app_type] => utility
[patent_app_number] => 16/204582
[patent_app_country] => US
[patent_app_date] => 2018-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13475
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16204582
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/204582 | Inhibitors of multidrug resistance transporter P-glycoprotein | Nov 28, 2018 | Issued |
Array
(
[id] => 14099129
[patent_doc_number] => 20190091240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => 17A-MONOESTERS AND 17A,21-DIESTERS OF CORTEXOLONE FOR USE IN THE TREATMENT OF TUMORS
[patent_app_type] => utility
[patent_app_number] => 16/199015
[patent_app_country] => US
[patent_app_date] => 2018-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16199015
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/199015 | 17a-monoesters and 17a,21-diesters of cortexolone for use in the treatment of tumors | Nov 22, 2018 | Issued |
Array
(
[id] => 16381980
[patent_doc_number] => 10806791
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Carbohydrate conjugates as delivery agents for oligonucleotides
[patent_app_type] => utility
[patent_app_number] => 16/196628
[patent_app_country] => US
[patent_app_date] => 2018-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 50
[patent_no_of_words] => 56699
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 224
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16196628
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/196628 | Carbohydrate conjugates as delivery agents for oligonucleotides | Nov 19, 2018 | Issued |
Array
(
[id] => 16483929
[patent_doc_number] => 20200377530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => SILANE MIXTURES AND PROCESS FOR PREPARING SAME
[patent_app_type] => utility
[patent_app_number] => 16/766524
[patent_app_country] => US
[patent_app_date] => 2018-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3324
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16766524
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/766524 | Silane mixtures and process for preparing same | Nov 15, 2018 | Issued |
Array
(
[id] => 16282579
[patent_doc_number] => 20200276181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => THIENOISOQUINOLINES AND THEIR DERIVATIVES FOR TARGETING TUBULIN, CH-TOG, AURORA A KINASE, TPX2, CDK5RAP2 AND/OR ASPM
[patent_app_type] => utility
[patent_app_number] => 16/764370
[patent_app_country] => US
[patent_app_date] => 2018-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16764370
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/764370 | THIENOISOQUINOLINES AND THEIR DERIVATIVES FOR TARGETING TUBULIN, CH-TOG, AURORA A KINASE, TPX2, CDK5RAP2 AND/OR ASPM | Nov 14, 2018 | Abandoned |